Overview

Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD

Status:
Unknown status

Trial end date:
2019-12-15

Target enrollment:

Participant gender:

Summary

Study to investigate the effects of symptom-driven maintenance and reliever therapy in COPD.

Phase:

Phase 3

Details

Lead Sponsor:

University Medical Center Groningen

Treatments:

Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Drug Combination
Formoterol Fumarate
Salmeterol Xinafoate
Xhance